Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review
Open Access
- 20 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Dystonia
- Vol. 1
Abstract
Cervical dystonia is the most common form of dystonia encountered in a movement disorders clinic. Botulinum toxin has been a long-established first line therapy. Several studies, including nearly two dozen randomized clinical trials, have shown that botulinum toxin is safe and effective in reducing the clinical severity of cervical dystonia. Longitudinal data have demonstrated decades of sustained benefit and safety. Although there is a potential for the development of botulinum toxin immunoresistance, this is quite rare, and partly determined by frequency of administration, cumulative dosage, and properties of the injected product. When immunoresistance does occur, switching to an alternative type of botulinum toxin (e.g., from type A to type B) usually restores the efficacy. In this evidence-based review we highlight the results of published double blind, placebo-controlled studies. We also briefly discuss injection techniques and some unmet needs, such as the development of practical assays to detect immunoresistance and longer-acting formulations of botulinum toxin.Keywords
This publication has 117 references indexed in Scilit:
- Immunogenicity of botulinum toxinsJournal of Neural Transmission, 2012
- Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapyJournal of Neural Transmission, 2012
- Should we reconsider the routine use of placebo controls in clinical research?Trials, 2012
- Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystoniaJournal of the Neurological Sciences, 2011
- Subthalamic nucleus deep brain stimulation in primary cervical dystoniaNeurology, 2011
- Levels of evidenceNeurology, 2009
- Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin AThe Journal of Physiology, 2008
- Drug regulation & therapeutic efficacyBritish Journal of Clinical Pharmacology, 2008
- Long‐term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystoniaMovement Disorders, 2004
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using DysportJournal of Neurology, Neurosurgery & Psychiatry, 1998